Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients

The indications for stereotactic body radiotherapy (SBRT) for prostate cancer have increased. However, the relationships between adverse events and risk factors remain unclear. This study aimed to clarify associations between adverse events and dose index for prostate SBRT. Participants comprised 14...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Kyohei, Nakano, Masahiro, Kawakami, Shogo, Tanaka, Yuichi, Kainuma, Takuro, Tsumura, Hideyasu, Tabata, Ken-ichi, Satoh, Takefumi, Iwamura, Masatsugu, Ishiyama, Hiromichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217554/
https://www.ncbi.nlm.nih.gov/pubmed/37232841
http://dx.doi.org/10.3390/curroncol30050383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217554/
https://www.ncbi.nlm.nih.gov/pubmed/37232841
http://dx.doi.org/10.3390/curroncol30050383

Ejemplares similares